scpharmaceuticals.com (SCPH) - Long-Term Debt to Capital Coefficient

The scPharmaceuticals Inc. (SCPH) price chart demonstrates the dynamics of an asset whose cash flow is steadily growing due to recognized heart failure treatment methods. The current indicator is 0.00. The business relies on strict control over the transportation of subcutaneous agents, guaranteeing the quality of therapy. The model generates profit through its resilience to market volatility, as demand for these drugs is independent of seasonality or economic conditions.

To objectively assess the operational resilience of scPharmaceuticals Inc. (SCPH), investors must understand the balance between debt and equity. Analyzing the long-term debt-to-capital ratio, which reflects the proportion of loans with maturities exceeding one year, allows for an assessment of leverage risk amid uncertainty regarding the commercial success of Furoscix and the challenges of securing insurance reimbursements with limited capital.